- Home
- SQNS vs ANIX Comparison
SQNS vs ANIX Comparison
Compare SQNS & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- ANIX
- Stock Information
- Founded
- SQNS 2003
- ANIX 1982
- Country
- SQNS France
- ANIX United States
- Employees
- SQNS N/A
- ANIX N/A
- Industry
- SQNS Semiconductors
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- ANIX Health Care
- Exchange
- SQNS Nasdaq
- ANIX Nasdaq
- Market Cap
- SQNS 46.5M
- ANIX 108.9M
- IPO Year
- SQNS 2011
- ANIX 1987
- Fundamental
- Price
- SQNS $2.59
- ANIX $3.44
- Analyst Decision
- SQNS Strong Buy
- ANIX Strong Buy
- Analyst Count
- SQNS 1
- ANIX 3
- Target Price
- SQNS $7.50
- ANIX $9.00
- AVG Volume (30 Days)
- SQNS 11.5M
- ANIX 113.8K
- Earning Date
- SQNS 07-31-2025
- ANIX 09-05-2025
- Dividend Yield
- SQNS N/A
- ANIX N/A
- EPS Growth
- SQNS N/A
- ANIX N/A
- EPS
- SQNS 2.16
- ANIX N/A
- Revenue
- SQNS $38,858,000.00
- ANIX N/A
- Revenue This Year
- SQNS N/A
- ANIX N/A
- Revenue Next Year
- SQNS $83.38
- ANIX N/A
- P/E Ratio
- SQNS $1.38
- ANIX N/A
- Revenue Growth
- SQNS 40.06
- ANIX N/A
- 52 Week Low
- SQNS $1.15
- ANIX $2.07
- 52 Week High
- SQNS $5.83
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- SQNS 54.00
- ANIX 58.14
- Support Level
- SQNS $2.75
- ANIX $3.18
- Resistance Level
- SQNS $5.83
- ANIX $3.24
- Average True Range (ATR)
- SQNS 0.75
- ANIX 0.12
- MACD
- SQNS 0.12
- ANIX -0.00
- Stochastic Oscillator
- SQNS 38.04
- ANIX 93.00
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.